禁煙を予測する. ニコチンパッチを入れても入れなくても禁煙する人はいますか?
S L Kenford1, M C Fiore, D E Jorenby
1Center for Tobacco Research and Intervention, University of Wisconsin Medical School, Madison 53706-1532.
JAMA
|February 23, 1994
まとめ
禁煙の成功は,ニコチンパッチ治療の重要な最初の2週間の禁欲によって予測されます. 早期喫煙は,パッチ付きであっても,再発を強く予測し,密接なモニタリングと介入の必要性を強調します.
科学分野:
- 依存症医学 薬物中毒医学
- 臨床心理学の臨床心理学について
- 薬理学 薬理学とは
背景:
- 禁煙は依然として公衆衛生上の大きな課題です.
- ニコチン置換療法 (NRT) とカウンセリングは,確立された介入です.
- 治療の成功の予測要因は,パーソナライズされた介入のさらなる解明を必要とします.
研究 の 目的:
- 禁煙の成功や失敗の予測要因を特定する.
- 皮膚経由のニコチンパッチ治療となしの予測要因を評価する.
- 長期的な禁煙の予測要因として,早期の喫煙行動の有用性を評価する.
主な方法:
- 2つの独立したランダム化,ダブルブラインド,プラセボ対照試験が行われました.
- 参加者は,毎日タバコを吸い,ニコチンパッチを使用し,さまざまなカウンセリングモードで,禁煙に意欲的でした.
- 喫煙状態は,治療の終わりと6ヶ月のフォローアップ時に評価されました.
主要な成果:
- 従来の治療前の予測指標 (例えば,ファガーストロームスコア,1日1本のタバコ) は,一貫して禁煙の成功を予測しなかった.
- ニコチンパッチ治療の第2週間の喫煙は,6ヶ月で失敗を予測する強力な指標でした.
- 対照的に,第2週間の禁煙は,アクティブグループとプラセボグループの両方で,成功する禁煙を予測しました.
結論:
- NRTの最初の2週間,特に2週間の喫煙状態は,禁煙の結果の強力な予測指標です.
- 早期喫煙行動は,プラセボ使用者でも重要な指標です.
- 臨床医は早期に完全な禁欲を強調し,禁煙後最初の2週間以内に患者を注意深く監視する必要があります.
関連する概念動画
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Drug Dependence
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
Stimulants
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
CNS Depressants: Alcohol and Nicotine
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
Cochran's Q Test
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square distribution,...

